AC Immune ACIU
NASDAQ ACIU
$2.72 -0.09 (-3.02%)
At close: Oct 2, 2026 · 4:00 PM EDT

AC Immune (ACIU) Depreciation and Depletion (2015 - 2025)

Updated

AC Immune's Depreciation and Depletion was $411,635 in the quarter ended Dec 31, 2025, up 0.4% from $409,806 a year earlier but down 3.2% from the prior quarter.

Analysis

AC Immune (ACIU) Depreciation and Depletion (2015 - 2025) Analysis & Trends

For the year ended Dec 31, 2025, Depreciation and Depletion at AC Immune came in at $1.68 million, down 0.5% from the prior year.

  • Depreciation and Depletion has now declined for four consecutive years, though with a five-year compound annual growth rate of 0.5% (years ended Dec 2020 to Dec 2025).
  • In earlier years, Depreciation and Depletion was $1.69 million in the year ended Dec 31, 2024 (-9.3%), $1.86 million in the year ended Dec 31, 2023 (-1.0%), $1.88 million in the year ended Dec 31, 2022 (-9.5%) and $2.08 million in the year ended Dec 31, 2021 (+26.8%).
  • Quarterly Depreciation and Depletion has moved between $401,522 (the quarter ended Mar 31, 2025) and $539,119 (the quarter ended Sep 30, 2021) over five years.
  • Compared with a year earlier, Depreciation and Depletion has increased for three straight quarters, with an average decline of 4.9% over the last eight quarters.
  • The best year-over-year quarter for Depreciation and Depletion over five years was the quarter ended Jun 30, 2021 (growth of 37.1%); the worst was the quarter ended Sep 30, 2022 (a decline of 15.9%).
  • Per Business Quant data, ACIU's Depreciation and Depletion in the three quarters before the quarter ended Dec 31, 2025 was $425,037 (quarter ended Sep 30, 2025), $438,464 (quarter ended Jun 30, 2025) and $401,522 (quarter ended Mar 31, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Depletion (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn -
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn -
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 194.00 Mn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn -
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 98.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 AC Immune 285.90 Mn 285.90 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 411,634.86
Sep 30, 2025 425,037.23
Jun 30, 2025 438,464.15
Mar 31, 2025 401,522.44
Dec 31, 2024 409,806.34
Sep 30, 2024 414,360.40
Jun 30, 2024 417,989.94
Mar 31, 2024 445,670.42
Dec 31, 2023 470,106.82
Sep 30, 2023 467,579.01
Jun 30, 2023 451,543.27
Mar 31, 2023 471,386.88
Dec 31, 2022 479,566.12
Sep 30, 2022 453,530.01
Jun 30, 2022 449,580.87
Mar 31, 2022 498,091.85
Dec 31, 2021 527,068.02
Sep 30, 2021 539,118.91
Jun 30, 2021 520,907.38
Mar 31, 2021 487,772.05
API Access

AC Immune Depreciation and Depletion API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=ACIU&period=max&api_key=YOUR_API_KEY